🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

International Biotechnology Trust plc (IBT)

London
Currency in GBP
715.80
+3.79(+0.53%)
Real-time Data
IBT Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
706.00716.00
52 wk Range
588.00734.00
Key Statistics
Edit
Bid/Ask
708.00 / 718.00
Prev. Close
712
Open
706
Day's Range
706-716
52 wk Range
588-734
Volume
47.88K
Average Volume (3m)
91.9K
1-Year Change
18.67%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IBT Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple
Show more

International Biotechnology Trust plc Company Profile

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund’s assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company’s assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.

Sector
Financial
Employees
0

Compare IBT to Peers and Sector

Metrics to compare
IBT
Peers
Sector
Relationship
P/E Ratio
6.6x6.0x8.8x
PEG Ratio
0.010.020.03
Price/Book
0.9x0.9x1.0x
Price / LTM Sales
6.0x5.5x2.8x
Upside (Analyst Target)
-0.0%11.1%
Fair Value Upside
Unlock24.8%2.5%Unlock

Analysts' Recommendations

1 Buy
0 Hold
0 Sell
Ratings:
0 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.00

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.02
Dividend Yield
3.99%
Industry Median 3.50%
Annualized payout
28.4000
Paid unevenly
5-Years Growth
+0.28%
Growth Streak

People Also Watch

221.95
FCSS
+1.35%
107.65
TFIF
-0.14%
344.78
PCT
+1.11%
165.50
HHI
-0.75%

FAQ

What Is the Intl Biotec (IBT) Stock Price Today?

The Intl Biotec stock price today is 715.80

What Stock Exchange Does Intl Biotec Trade On?

Intl Biotec is listed and trades on the London stock exchange.

What Is the Stock Symbol for Intl Biotec?

The stock symbol for Intl Biotec is "IBT."

Does Intl Biotec Pay Dividends? What’s The Current Dividend Yield?

The Intl Biotec dividend yield is 3.99%.

What Is the Intl Biotec Market Cap?

As of today, Intl Biotec market cap is 259.68M.

What is Intl Biotec Earnings Per Share?

The Intl Biotec EPS is 1.02.

From a Technical Analysis Perspective, Is IBT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.